Literature DB >> 1287942

Complement pathway activity in serum from patients with classical dengue fever.

M F Shaio1, F Y Chang, S C Hou.   

Abstract

Complement activity in 125 cases of classical dengue fever was examined through the measurement of haemolytic activity. During the first 3 d of fever, the classical complement pathway activity (CCPA) was not altered in 109 cases. After 4 d of fever, 9 of 16 patients in the viraemic period had CCPA decreased by 45% (995 +/- 119 units/ml) and serum complement component C4 decreased by 40% (10.4 +/- 0.9 mg/dl). The alternative complement pathway activity was not affected in any case tested throughout both viraemic and convalescent stages. Both CCPA and C4 persistently decreased in 3 of these 9 patients at the convalescent stage. A decrease in serum C3 was also observed in these 3 patients only, and circulating immune complexes (CIC) levels were particularly high in these 3 patients. These results indicate that there is little evidence of complement activation on days 1-3 of viraemia but that complement activation may occur subsequently. It is concluded that both CIC and other unknown factors not related to CIC may contribute to complement activation in some cases (9/125) of classical dengue fever.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1287942     DOI: 10.1016/0035-9203(92)90186-g

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  9 in total

Review 1.  Dengue epidemiology and pathogenesis: images of the future viewed through a mirror of the past.

Authors:  Rashedul Islam; Mohammed Salahuddin; Md Salahuddin Ayubi; Tahmina Hossain; Apurba Majumder; Andrew W Taylor-Robinson; Abdullah Mahmud-Al-Rafat
Journal:  Virol Sin       Date:  2015-10-20       Impact factor: 4.327

2.  Serum proteome changes in dengue virus-infected patients from a dengue-endemic area of India: towards new molecular targets?

Authors:  Sandipan Ray; Rajneesh Srivastava; Karnika Tripathi; Vineet Vaibhav; Swati Patankar; Sanjeeva Srivastava
Journal:  OMICS       Date:  2012-08-23

3.  Infection-enhancing and -neutralizing activities of mouse monoclonal antibodies against dengue type 2 and 4 viruses are controlled by complement levels.

Authors:  Atsushi Yamanaka; Saori Kosugi; Eiji Konishi
Journal:  J Virol       Date:  2007-11-14       Impact factor: 5.103

Review 4.  Dengue virus pathogenesis: an integrated view.

Authors:  Byron E E Martina; Penelope Koraka; Albert D M E Osterhaus
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

5.  Both virus and tumor necrosis factor alpha are critical for endothelium damage in a mouse model of dengue virus-induced hemorrhage.

Authors:  Hsuen-Chin Chen; Florence M Hofman; John T Kung; Yang-Ding Lin; Betty A Wu-Hsieh
Journal:  J Virol       Date:  2007-03-14       Impact factor: 5.103

Review 6.  In the Crosshairs: RNA Viruses OR Complement?

Authors:  Nisha Asok Kumar; Umerali Kunnakkadan; Sabu Thomas; John Bernet Johnson
Journal:  Front Immunol       Date:  2020-09-29       Impact factor: 7.561

7.  Evidence of dengue virus in eviscerated specimens of panophthalmitis secondary to dengue fever: A possible cause-effect phenomenon.

Authors:  Tarjani V Dave; Savitri Sharma; Vemu Lakshmi; Ashok Rangaiahgari; Somasheila I Murthy; Mohammad J Ali; Vivek P Dave; Rajeev R Pappuru
Journal:  Indian J Ophthalmol       Date:  2022-03       Impact factor: 2.969

8.  Roles for endothelial cells in dengue virus infection.

Authors:  Nadine A Dalrymple; Erich R Mackow
Journal:  Adv Virol       Date:  2012-08-16

Review 9.  Manipulation of cell surface macromolecules by flaviviruses.

Authors:  Robert Anderson
Journal:  Adv Virus Res       Date:  2003       Impact factor: 9.937

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.